Company tag
PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB)
Articles
United States drug policy will mean increasing costs for private insurance plans
May 30, 2025
Prescription drug expenditures rebound following the COVID-19 pandemic
February 27, 2025
Insurers must manage drug cost inflation in 2025
January 21, 2025
Canadian medicine prices remain higher than all price board reference countries
December 11, 2024
Health Canada approval rate for medicines edges above five-year average
May 28, 2024
Canadian list prices for patented medicines remain among the highest in the world
February 20, 2024
Public drug plans not immune to the rising cost of medications
January 17, 2024
Industry advises Patented Medicines Pricing Review Board on new guidelines
December 22, 2023
